Vital Farms director buys 4,750 company shares

Vital Farms, Inc. director William B. Cyr bought 4,750 shares of common stock in an open-market purchase on March 2, 2026 at a weighted average price of $20.70 per share.

Rhea-AI Filing Summary

Vital Farms, Inc. director William B. Cyr bought 4,750 shares of common stock in an open-market purchase on March 2, 2026 at a weighted average price of $20.70 per share. The trades occurred at prices ranging from $20.58 to $20.71. After this transaction, he directly owns 7,794 shares.

Insider Trade Summary

Net Buyer: 4,750 shares

Net Buy 1 txn

Insider Cyr William B.

Role Director

Bought 4,750 shs ($98K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	4,750	$20.70	$98K

Holdings After Transaction: Common Stock — 7,794 shares (Direct)

Footnotes (1)

1. F1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $20.58 to $20.71 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

FAQ

What insider transaction did Vital Farms (VITL) report for William B. Cyr?

Vital Farms reported that director William B. Cyr bought 4,750 shares of common stock. The open-market purchase occurred on March 2, 2026 at a weighted average price of $20.70 per share, increasing his direct ownership to 7,794 shares after the transaction.

At what price did William B. Cyr buy Vital Farms (VITL) shares?

William B. Cyr bought 4,750 Vital Farms shares at a weighted average price of $20.70. According to the filing footnote, individual trades were executed in a price range from $20.58 to $20.71 per share during the March 2, 2026 open-market purchase.

How many Vital Farms (VITL) shares does William B. Cyr own after this trade?

After the March 2, 2026 purchase, William B. Cyr directly owns 7,794 Vital Farms common shares. This reflects the addition of 4,750 shares acquired in the open-market transaction at a weighted average price of $20.70 per share, as disclosed in the insider filing.

Was the Vital Farms (VITL) insider transaction a buy or a sell?

The reported Vital Farms insider transaction was a buy. Director William B. Cyr executed an open-market purchase of 4,750 common shares on March 2, 2026 at a weighted average price of $20.70, with no stock sales reported in this Form 4 filing.

What does the price range in the Vital Farms (VITL) Form 4 footnote mean?

The footnote explains that the $20.70 price is a weighted average for multiple trades. Individual purchase transactions were executed between $20.58 and $20.71 per share, and detailed trade-by-trade pricing information is available from the company, its shareholders, or the SEC staff upon request.

What role does William B. Cyr have at Vital Farms (VITL) in this insider filing?

In this insider filing, William B. Cyr is identified as a director of Vital Farms. The Form 4 reports his open-market purchase of 4,750 common shares on March 2, 2026, which increased his directly owned position to a total of 7,794 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/04/2026 - 05:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cyr William B.

(Last) (First) (Middle)

C/O VITAL FARMS, INC.

3601 SOUTH CONGRESS AVENUE

(Street)

AUSTIN TX 78704

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vital Farms, Inc. [ VITL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/02/2026		P		4,750	A	$20.7(1)	7,794	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $20.58 to $20.71 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

	/s/ Francis Cullo, Attorney-in-Fact	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.